ZAP Surgical Systems obtains $78M to commercialize gyroscopic radiosurgery platform

ZAP Surgical developed ZAP-X for the streamlined treatment of brain tumors, lesions, and other conditions of the head and neck. | Source: ZAP Surgical Systems

ZAP Surgical Systems Inc. this week said it has successfully closed a $78 million Series E funding round. The developer of non-invasive, robotic brain-surgery tools said the new financing will advance the commercialization of its ZAP-X Gyroscopic Radiosurgery platform.

Stereotactic radiosurgery (SRS) is a well-established procedure...